Press Releases Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Market Closed - Australian S.E. Other stock markets 11:40:14 09/05/2024 am IST			5-day change	1st Jan Change
15.35 ^AUD	+0.46%		+3.72%	+52.28%

03/05	Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP	MT
30/04	Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Telix to Showcase Extensive Urologic Pipeline at AUA Annual Meeting including Phase III ProstACT GLOBAL Study of TLX591	01/05	AQ
Telix - Notice of Annual General Meeting 2024	22/04	AQ
Q1 2024 Revenue and Business Update	17/04	AQ
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation	16/04	AQ
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.	11/04	BU
Telix Pharmaceuticals - World First Use of Lightpoint's SENSEI Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain	27/03	AQ
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain	27/03	AQ
QDOSE Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy	19/03	AQ
QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy	19/03	AQ
Appointment of Dr Darren Patti to Group Chief Operating Officer	12/03	AQ
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform	05/03	AQ
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics	27/02	AQ
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline	22/02	AQ
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform	08/02	AQ
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals	08/02	AQ
Telix Full Year Results 2023 Investor Webcast Notification	07/02	AQ
MAUNA KEA TECHNOLOGIES REPORTS FULL YEAR 2023 SALES OF EUR10.5M, UP +42% VS 2022	26/01	AQ
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)	22/01	AQ
Telix Announces Planned Registered Public Offering and Listing in the United States	05/01	AQ
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Press Releases

Filters